THE NATIONAL ACADEMIES OF SCIENCES, ENGINEERING, AND MEDICINE
Division on Earth and Life Studies
Board on Life Sciences
Board on Agriculture and Natural Resources
Board on Chemical Sciences and Technology
Committee on Future Biotechnology Products and Opportunities to Enhance
Capabilities of the Biotechnology Regulatory System
Preparing for Future Products of Biotechnology
Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 5–10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology?
This new report, from the National Academies of Sciences, Engineering, and Medicine, analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.